[Federal Register Volume 78, Number 43 (Tuesday, March 5, 2013)]
[Rules and Regulations]
[Pages 14179-14183]
[FR Doc No: 2013-04931]

=======================================================================
-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

17 CFR Part 201

[Release Nos. 33-9387; 34-68994; IA-3557; IC-30408]

Adjustments to Civil Monetary Penalty Amounts

AGENCY: Securities and Exchange Commission.

ACTION: Final rule.

-----------------------------------------------------------------------

SUMMARY: This rule implements the Federal Civil Penalties Inflation
Adjustment Act of 1990, as amended by the Debt Collection Improvement
Act of 1996. The Commission is adopting a rule adjusting for inflation
the maximum amount of civil monetary penalties under the Securities Act
of 1933, the Securities Exchange Act of 1934, the Investment Company
Act of 1940, the Investment Advisers Act of 1940, and certain penalties
under the Sarbanes-Oxley Act of 2002.

DATES: Effective Date: March 5, 2013.

FOR FURTHER INFORMATION CONTACT: James A. Cappoli, Senior Special
Counsel, Office of the General Counsel, at<PHONE_NUMBER>, or Miles S.
Treakle, Senior Counsel, Office of the General Counsel, at (202) 551-
3609.

SUPPLEMENTARY INFORMATION:

I. Background

    This rule implements the Debt Collection Improvement Act of 1996
(``DCIA'').\1\ The DCIA amended the Federal Civil Penalties Inflation
Adjustment Act of 1990 (``FCPIAA'') \2\ to require each federal agency
to adopt regulations at least once every four years that adjust for
inflation the maximum amount of the civil monetary penalties (``CMPs'')
under the statutes administered by the agency.\3\
---------------------------------------------------------------------------

    \1\ Public Law 104-134, 110 Stat. 1321-373 (1996) (codified at
28 U.S.C. 2461 note).
    \2\ 28 U.S.C. 2461 note.
    \3\ Increased CMPs apply only to violations that occur after the
increase takes effect.
---------------------------------------------------------------------------

    A civil monetary penalty (``CMP'') is defined in relevant part as
any penalty, fine, or other sanction that: (1) Is for a specific
amount, or has a maximum amount, as provided by federal law; and (2) is
assessed or enforced by an agency in an administrative proceeding or by
a federal court pursuant to federal law.\4\ This definition covers the
monetary penalty provisions contained in the statutes administered by
the Commission. In addition, this definition encompasses the civil
monetary penalties that may be imposed by the Public Company Accounting
Oversight Board (the ``PCAOB'') in its disciplinary proceedings
pursuant to 15 U.S.C. 7215(c)(4)(D).\5\
---------------------------------------------------------------------------

    \4\ 28 U.S.C. 2461 note (3)(2).
    \5\ The Commission may by order affirm, modify, remand, or set
aside sanctions, including civil monetary penalties, imposed by the
PCAOB. See Section 107(c) of the Sarbanes-Oxley Act of 2002, 15
U.S.C. 7217. The Commission may enforce such orders in federal
district court pursuant to Section 21(e) of the Securities Exchange
Act of 1934. As a result, penalties assessed by the PCAOB in its
disciplinary proceedings are penalties ``enforced'' by the
Commission for purposes of the Act. See Adjustments to Civil
Monetary Penalty Amounts, Release No. 33-8530 (Feb. 4, 2005) [70 FR
7606 (Feb. 14, 2005)].
---------------------------------------------------------------------------

    The DCIA requires that the penalties be adjusted by the cost-of-
living adjustment set forth in Section 5 of the FCPIAA.\6\ The cost-of-
living adjustment is defined in the FCPIAA as the percentage by which
the U.S. Department of Labor's Consumer Price Index for all-urban
consumers (``CPI-U'') \7\ for the month of June for the year preceding
the adjustment exceeds the CPI-U for the month of June for the year in
which the amount of the penalty was last set or adjusted pursuant to
law.\8\ The statute contains specific rules for rounding each increase
based on the size of the penalty.\9\ Agencies do not have discretion
over whether to adjust a maximum CMP, or the method used

to determine the adjustment. Although the DCIA imposes a 10 percent
maximum increase for each penalty for the first adjustment pursuant
thereto, that limitation does not apply to subsequent adjustments.
---------------------------------------------------------------------------

    \6\ 28 U.S.C. 2461 note (5).
    \7\ 28 U.S.C. 2461 note (3)(3).
    \8\ 28 U.S.C. 2461 note (5)(b).
    \9\ 28 U.S.C. 2461 note (5)(a)(1)-(6).
---------------------------------------------------------------------------

    The Commission administers four statutes that provide for civil
monetary penalties: The Securities Act of 1933; the Securities Exchange
Act of 1934; the Investment Company Act of 1940; and the Investment
Advisers Act of 1940. In addition, the Sarbanes-Oxley Act of 2002
provides the PCAOB (over which the Commission has jurisdiction)
authority to levy civil monetary penalties in its disciplinary
proceedings.\10\ Penalties administered by the Commission were last
adjusted by rules effective March 3, 2009.\11\ The DCIA requires the
civil monetary penalties to be adjusted for inflation at least once
every four years. The Commission is therefore obligated by statute to
increase the maximum amount of each penalty by the appropriate
formulated amount.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 7215(c)(4)(D).
    \11\ See 17 CFR 201.1004.
---------------------------------------------------------------------------

    Accordingly, the Commission is adopting an amendment to 17 CFR part
201 to add Sec.  201.1005 and Table V to Subpart E, increasing the
amount of each civil monetary penalty authorized by the Securities Act
of 1933, the Securities Exchange Act of 1934, the Investment Company
Act of 1940, the Investment Advisers Act of 1940, and certain penalties
under the Sarbanes-Oxley Act of 2002.\12\ The adjustments set forth in
the amendment apply to violations occurring after the effective date of
the amendment.
---------------------------------------------------------------------------

    \12\ The Commission also is adopting technical corrections to
Table I, Table II, Table III, and Table IV of 17 CFR Part 201. 17
CFR 201.1001-1004. Each of these tables referenced 15 U.S.C.
78ff(c)(2)(C), rather than 15 U.S.C. 78ff(c)(2)(B). The technical
corrections will amend each table to refer to the correct paragraph.
---------------------------------------------------------------------------

II. Summary of the Calculation

    To explain the inflation adjustment calculation for CMP amounts
that were last adjusted in 2009, we will use the following example.
Under the current provisions, the Commission may impose a maximum CMP
of $1,425,000 for certain insider trading violations by a controlling
person. To determine the new CMP amounts under the amendment, first we
determine the appropriate CPI-U for June of the calendar year preceding
the year of adjustment. Because we are adjusting CMPs in 2013, we use
the CPI-U for June of 2012, which was 229.478. We must also determine
the CPI-U for June of the year the CMP was last adjusted for inflation.
Because the Commission last adjusted this CMP in 2009, we use the CPI-U
for June of 2009, which was 215.693.
    Second, we calculate the cost-of-living adjustment or inflation
factor. To do this we divide the CPI for June of 2012 (229.478) by the
CPI for June of 2009 (215.693). Our result is 1.0639.
    Third, we calculate the raw inflation adjustment (the inflation
adjustment before rounding). To do this, we multiply the maximum
penalty amounts by the inflation factor. In our example, $1,425,000
multiplied by the inflation factor of 1.0639 equals $1,516,058.
    Fourth, we round the raw inflation amounts according to the
rounding rules in Section 5(a) of the FCPIAA. Since we round only the
increase amount, we calculate the increased amount by subtracting the
current maximum penalty amounts from the raw maximum inflation
adjustments. Accordingly, the increase amount for the maximum penalty
in our example is $91,072 (i.e., $1,516,058 less $1,425,000). Under the
rounding rules, if the penalty is greater than $200,000, we round the
increase to the nearest multiple of $25,000. Therefore, the maximum
penalty increase in our example is $100,000.
    Fifth, we add the rounded increase to the maximum penalty amount
last set or adjusted. In our example, $1,425,000 plus $100,000 yields a
maximum inflation adjustment penalty amount of $1,525,000.\13\
---------------------------------------------------------------------------

    \13\ The adjustments in Table V to Subpart E of Part 201 reflect
that the operation of the statutorily mandated computation, together
with rounding rules, does not result in any adjustment to ten
penalties. These particular penalties will be subject to slightly
different treatment when calculating the next adjustment. Under the
statute, when we next adjust these penalties, we will be required to
use the CPI-U for June of the year when these particular penalties
were ``last adjusted,'' rather than the CPI-U for 2013.
---------------------------------------------------------------------------

III. Related Matters

Administrative Procedure Act--Immediate Effectiveness of Final Rule

    Under the Administrative Procedure Act (``APA''), a final rule may
be issued without public notice and comment if the agency finds good
cause that notice and comment are impractical, unnecessary, or contrary
to public interest.\14\ Because the Commission is required by statute
to adjust the civil monetary penalties within its jurisdiction by the
cost-of-living adjustment formula set forth in Section 5 of the FCPIAA,
the Commission finds that good cause exists to dispense with public
notice and comment pursuant to the notice and comment provisions of the
APA.\15\ Specifically, the Commission finds that because the adjustment
is mandated by Congress and does not involve the exercise of Commission
discretion or any policy judgments, public notice and comment is
unnecessary.\16\
---------------------------------------------------------------------------

    \14\ 5 U.S.C. 553(b)(3)(B).
    \15\ 5 U.S.C. 553(b)(3)(B).
    \16\ A regulatory flexibility analysis under the Regulatory
Flexibility Act (``RFA'') is required only when an agency must
publish a general notice of proposed rulemaking for notice and
comment. See 5 U.S.C. 603. As noted above, notice and comment are
not required for this final rule. Therefore, the RFA does not apply.
---------------------------------------------------------------------------

    Under the DCIA, agencies must make the required inflation
adjustment to civil monetary penalties: (1) According to a very
specific formula in the statute; and (2) within four years of the last
inflation adjustment. Agencies have no discretion as to the amount of
the adjustment and have limited discretion as to the timing of the
adjustment, in that agencies are required to make the adjustment at
least once every four years. The regulation discussed herein is
ministerial, technical, and noncontroversial. Furthermore, because the
regulation concerns penalties for conduct that is already illegal under
existing law, there is no need for affected parties to have thirty days
prior to the effectiveness of the regulation and amendments to adjust
their conduct. Accordingly, the Commission believes that there is good
cause to make this regulation effective immediately upon
publication.\17\
---------------------------------------------------------------------------

    \17\ Additionally, this finding satisfies the requirements for
immediate effectiveness under the Small Business Regulatory
Enforcement Fairness Act. See 5 U.S.C. 808(2); see also id.
801(a)(4).
---------------------------------------------------------------------------

A. Economic Analysis

    The Commission is sensitive to the costs and benefits that result
from its rules. This regulation merely adjusts civil monetary penalties
in accordance with inflation as required by the DCIA, and has no impact
on disclosure or compliance costs. The Commission notes that the civil
monetary penalties ordered in SEC proceedings in fiscal year 2012
totaled approximately $1,021.0 million. Assuming that the Commission is
successful in obtaining civil monetary penalties in fiscal years
subsequent to the enactment of the new regulation in similar proportion
to that obtained in fiscal year 2012, the inflationary adjustment
pursuant to the new regulation would result in a maximum increase in
the civil monetary penalties ordered of approximately 6.4%, or $65.3
million. This figure assumes that the Commission would obtain a civil
monetary penalty equal to the maximum statutory amount in each

case, which clearly overstates the effect of the adjustment to the
penalties. The Commission further notes that, in many cases in which it
has obtained large civil monetary penalties, such penalties were
calculated on the basis of the gross pecuniary gain rather than the
maximum penalty dollar amount set by statute that will be adjusted by
this rule.\18\ In addition, the Commission notes that this figure
includes penalties imposed for insider trading, for which the statutory
maximum is stated as an amount not to exceed three times the profit
gained or loss avoided as a result of the violation, rather than by
reference to a statutory dollar amount that is affected by this
regulation.\19\ Therefore, the Commission does not believe that
adjusting civil monetary penalties will significantly affect the amount
of penalties it obtains.
---------------------------------------------------------------------------

    \18\ For example, 15 U.S.C. 77t(d)(2)(A), after adjusting for
inflation as required by the DCIA, provides that ``the amount of the
penalty shall not exceed the greater of (i) [$7,500] for a natural
person or [$80,000] for any other person, or (ii) the gross amount
of pecuniary gain to such defendant as a result of the violation.''
    \19\ 15 U.S.C. 78u-1(a)(2). In fiscal year 2012, penalties
imposed under this provision totaled over $140 million.
---------------------------------------------------------------------------

    The benefit provided by the inflationary adjustment to the maximum
civil monetary penalties is that of maintaining the level of deterrence
effectuated by the civil monetary penalties, and not allowing such
deterrent effect to be diminished by inflation. The costs of
implementing this rule should be negligible, because the only change
from the current, baseline situation is determining potential penalties
using a new maximum dollar amount. Furthermore, Congress, in mandating
the inflationary adjustments, has already determined that any possible
increase in costs is justified by the overall benefits of such
adjustments.

B. Paperwork Reduction Act

    This rule does not contain any collection of information
requirements as defined by the Paperwork Reduction Act of 1995 as
amended.\20\
---------------------------------------------------------------------------

    \20\ 44 U.S.C. 3501 et seq.
---------------------------------------------------------------------------

C. Statutory Basis

    The Commission is adopting these amendments to 17 CFR Part 201,
Subpart E pursuant to the directives and authority of the DCIA, Pub. L.
No. 104-134, 110 Stat. 1321-373 (1996).

List of Subjects in 17 CFR Part 201

    Administrative practice and procedure, Claims, Confidential
business information, Lawyers, Securities.

Text of Amendment

    For the reasons set forth in the preamble, part 201, title 17,
chapter II of the Code of Federal Regulations is amended as follows:

PART 201--RULES OF PRACTICE

Subpart E--Adjustment of Civil Monetary Penalties

0
1. The authority citation for part 201, Subpart E, continues to read as
follows:

    Authority: 28 U.S.C. 2461 note.

Sec.  201.1001  [Amended]

0
2. Section 201.1001 is amended in Table 1 in the first column labeled
``U.S. code citation'' by removing the reference ``15 U.S.C.
78ff(c)(2)(C) * * *'' and adding in its place ``15 U.S.C. 78ff(c)(2)(B)
* * *''.

Sec.  201.1002  [Amended]

0
3. Section 201.1002 is amended in Table II in the first column labeled
``U.S. code citation'' by removing the reference ``15 U.S.C.
78ff(c)(2)(C) * * *'' and adding in its place ``15 U.S.C. 78ff(c)(2)(B)
* * *''.

Sec.  201.1003  [Amended]

0
4. Section 201.1003 is amended in Table III in the first column labeled
``U.S. code citation'' by removing the reference ``15 U.S.C.
78ff(c)(2)(C) * * *.'' and adding in its place ``15 U.S.C.
78ff(c)(2)(B) * * *''.

Sec.  201.1004  [Amended]

0
5. Section 201.1004 is amended in Table IV in the first column labeled
``U.S. code citation'' by removing the reference ``15 U.S.C.
78ff(c)(2)(C) * * *'' and adding in its place ``15 U.S.C. 78ff(c)(2)(B)
* * *''.

0
6. Section 201.1005 and Table V to Subpart E are added to read as
follows:

Sec.  201.1005  Adjustment of civil monetary penalties--2013.

    As required by the Debt Collection Improvement Act of 1996, the
maximum amounts of all civil monetary penalties under the Securities
Act of 1933, the Securities Exchange Act of 1934, the Investment
Company Act of 1940, the Investment Advisers Act of 1940, and certain
penalties under the Sarbanes-Oxley Act of 2002 are adjusted for
inflation in accordance with Table V to this subpart. The adjustments
set forth in Table V apply to violations occurring after March 5, 2013.

----------------------------------------------------------------------------------------------------------------
         Table V to subpart E            Civil monetary penalty                       Maximum
---------------------------------------   inflation adjustments                       penalty
                                       --------------------------  Year penalty       amount         Adjusted
                                                                    amount was     pursuant  to       maximum
          U.S. Code citation             Civil monetary penalty    last adjusted       last       penalty amount
                                               description                          adjustment
----------------------------------------------------------------------------------------------------------------
Securities and Exchange Commission:
    15 U.S.C. 77h-1(g)................  For natural person......            2010          $7,500          $7,500
                                        For any other person....            2010          75,000          80,000
                                        For natural person/fraud            2010          75,000          80,000
                                        For any other person/               2010         375,000         400,000
                                         fraud.
                                        For natural person/                 2010         150,000         160,000
                                         substantial losses or
                                         risk of losses to
                                         others.
                                        For any other person/               2010         725,000         775,000
                                         substantial losses or
                                         risk of losses to
                                         others.
    15 U.S.C. 77t(d)..................  For natural person......            2009           7,500           7,500
                                        For any other person....            2009          75,000          80,000
                                        For natural person/fraud            2009          75,000          80,000
                                        For any other person/               2009         375,000         400,000
                                         fraud.
                                        For natural person/                 2009         150,000         160,000
                                         substantial losses or
                                         risk of losses to
                                         others.
                                        For any other person/               2009         725,000         775,000
                                         substantial losses or
                                         risk of losses to
                                         others.

    15 U.S.C. 78ff(b).................  Exchange Act/failure to             1996             110             210
                                         file information
                                         documents, reports.
    15 U.S.C. 78ff(c)(1)(B)...........  Foreign Corrupt                     2009          16,000          16,000
                                         Practices--any issuer.
    15 U.S.C. 78ff(c)(2)(B)...........  Foreign Corrupt                     2009          16,000          16,000
                                         Practices--any agent or
                                         stockholder acting on
                                         behalf of issuer.
    15 U.S.C. 78u-1(a)(3).............  Insider Trading--                   2009       1,425,000       1,525,000
                                         controlling person.
    15 U.S.C. 78u-2...................  For natural person......            2009           7,500           7,500
                                        For any other person....            2009          75,000          80,000
                                        For natural person/fraud            2009          75,000          80,000
                                        For any other person/               2009         375,000         400,000
                                         fraud.
                                        For natural person/                 2009         150,000         160,000
                                         substantial losses to
                                         others/gains to self.
                                        For any other person/               2009         725,000         775,000
                                         substantial losses to
                                         others/gain to self.
    15 U.S.C. 78u(d)(3)...............  For natural person......            2009           7,500           7,500
                                        For any other person....            2009          75,000          80,000
                                        For natural person/fraud            2009          75,000          80,000
                                        For any other person/               2009         375,000         400,000
                                         fraud.
                                        For natural person/                 2009         150,000         160,000
                                         substantial losses or
                                         risk of losses to
                                         others.
                                        For any other person/               2009         725,000         775,000
                                         substantial losses or
                                         risk of losses to
                                         others.
    15 U.S.C. 80a-9(d)................  For natural person......            2009           7,500           7,500
                                        For any other person....            2009          75,000          80,000
                                        For natural person/fraud            2009          75,000          80,000
                                        For any other person/               2009         375,000         400,000
                                         fraud.
                                        For natural person/                 2009         150,000         160,000
                                         substantial losses to
                                         others/gains to self.
                                        For any other person/               2009         725,000         775,000
                                         substantial losses to
                                         others/gain to self.
    15 U.S.C. 80a-41(e)...............  For natural person......            2009           7,500           7,500
                                        For any other person....            2009          75,000          80,000
                                        For natural person/fraud            2009          75,000          80,000
                                        For any other person/               2009         375,000         400,000
                                         fraud.
                                        For natural person/                 2009         150,000         160,000
                                         substantial losses or
                                         risk of losses to
                                         others.
                                        For any other person/               2009         725,000         775,000
                                         substantial losses or
                                         risk of losses to
                                         others.
    15 U.S.C. 80b-3(i)................  For natural person......            2009           7,500           7,500
                                        For any other person....            2009          75,000          80,000
                                        For natural person/fraud            2009          75,000          80,000
                                        For any other person/               2009         375,000         400,000
                                         fraud.
                                        For natural person/                 2009         150,000         160,000
                                         substantial losses to
                                         others/gains to self.
                                        For any other person/               2009         725,000         775,000
                                         substantial losses to
                                         others/gain to self.
    15 U.S.C. 80b-9(e)................  For natural person......            2009           7,500           7,500
                                        For any other person....            2009          75,000          80,000
                                        For natural person/fraud            2009          75,000          80,000
                                        For any other person/               2009         375,000         400,000
                                         fraud.
                                        For natural person/                 2009         150,000         160,000
                                         substantial losses or
                                         risk of losses to
                                         others.
                                        For any other person/               2009         725,000         775,000
                                         substantial losses or
                                         risk of losses to
                                         others.
    15 U.S.C. 7215(c)(4)(D)(i)........  For natural person......            2009         120,000         130,000
                                        For any other person....            2009       2,375,000       2,525,000
    15 U.S.C. 7215(c)(4)(D)(ii).......  For natural person......            2009         900,000         950,000
                                        For any other person....            2009      17,800,000      18,925,000
----------------------------------------------------------------------------------------------------------------

    Dated: February 27, 2013.
    By the Commission.
Elizabeth M. Murphy,
Secretary.
[FR Doc. 2013-04931 Filed 3-4-13; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 149 (Thursday, August 2, 2012)]
[Proposed Rules]
[Pages 45981-45983]
[FR Doc No: 2012-18588]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 39

[Docket No. FAA-2012-0726; Directorate Identifier 2012-NM-023-AD]
RIN 2120-AA64

Airworthiness Directives; Bombardier, Inc. Airplanes

AGENCY: Federal Aviation Administration (FAA), DOT.

ACTION: Notice of proposed rulemaking (NPRM).

-----------------------------------------------------------------------

SUMMARY: We propose to adopt a new airworthiness directive (AD) for
certain Bombardier, Inc. Model DHC-8-400 series airplanes. This
proposed AD was prompted by cases of on-ground failure of the screw cap
or end cap of hydraulic accumulators on other airplane models,
resulting in high-energy impact damage to adjacent systems and
structure. This proposed AD would require inspecting for a part number
and replacing the affected parking brake hydraulic accumulator, and
relocating the parking brake accumulator, on the subject airplanes. We
are proposing this AD to prevent failure of the screw caps and/or end
caps of the parking brake hydraulic accumulator, which could result in
damage to the airplane's primary structures, with potential adverse
effect on the airplane's controllability.

DATES: We must receive comments on this proposed AD by September 17,
2012.

ADDRESSES: You may send comments by any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC 20590.
     Hand Delivery: U.S. Department of Transportation, Docket
Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
    For service information identified in this proposed AD, contact
Bombardier, Inc., Q-Series Technical Help Desk, 123 Garratt Boulevard,
Toronto, Ontario M3K 1Y5, Canada; telephone<PHONE_NUMBER>; fax 416-375-
4539; email<EMAIL_ADDRESS>Internet http://www.bombardier.com. You may review copies of the referenced service
information at the FAA, Transport Airplane Directorate, 1601 Lind
Avenue SW., Renton, Washington. For information on the availability of
this material at the FAA, call<PHONE_NUMBER>.

Examining the AD Docket

    You may examine the AD docket on the Internet at http://www.regulations.gov; or in person at the Docket Operations office
between 9 a.m. and 5 p.m., Monday through Friday, except Federal
holidays. The AD docket contains this proposed AD, the regulatory
evaluation, any comments received, and other information. The street
address for the Docket Operations office (telephone<PHONE_NUMBER>) is
in the ADDRESSES section. Comments will be available in the AD docket
shortly after receipt.

FOR FURTHER INFORMATION CONTACT: Cesar Gomez, Aerospace Engineer,
Airframe and Mechanical Systems Branch, ANE-171, FAA, New York Aircraft
Certification Office, 1600 Stewart Avenue, Suite 410, Westbury, New
York 11590; telephone<PHONE_NUMBER>; fax<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

Comments Invited

    We invite you to send any written relevant data, views, or
arguments about this proposed AD. Send your comments to an address
listed under the ADDRESSES section. Include ``Docket No. FAA-2012-0726;
Directorate Identifier 2012-NM-023-AD'' at the beginning of your
comments. We specifically invite comments on the overall regulatory,
economic, environmental, and energy aspects of this proposed AD. We
will consider all comments received by the closing date and may amend
this proposed AD based on those comments.
    We will post all comments we receive, without change, to http://www.regulations.gov, including any personal information you provide. We
will also post a report summarizing each substantive verbal contact we
receive about this proposed AD.

Discussion

    Transport Canada Civil Aviation (TCCA), which is the aviation
authority for Canada, has issued Canadian Airworthiness Directive CF-
2012-04, dated January 13, 2012 (referred to after this as ``the
MCAI''), to correct an unsafe condition for the specified products. The
MCAI states:

    Seven cases of on-ground hydraulic accumulator/screw cap/end cap
failure have been experienced on CL-600-2B19 (CRJ) aeroplanes,
resulting in loss of the associated hydraulic system and high-energy
impact

damage to adjacent systems and structure. To date, the lowest number
of flight cycles accumulated at the time of failure has been 6991.
    Although there have been no failures to date on any DHC-8
aeroplanes, similar accumulators to those installed on the CL-600-
2B19, Part Number (P/N) 08-60197-001 (Parking Brake Accumulator),
are installed on the aeroplanes listed in the Applicability section
of this Airworthiness Directive (AD). It was also found that some of
these accumulators may be affected by manufacturing non-
conformances.
    A detailed analysis of the systems and structure in the
potential line of trajectory of a failed screw cap/end cap for the
accumulator has been conducted. It has been identified that the
worst-case scenarios would be the damage to the aeroplane's primary
structures, which could have an adverse effect on the
controllability of the aeroplane.
    This AD mandates the [inspection for part and serial numbers
and] replacement of the affected hydraulic accumulators and the
relocation of the parking brake accumulator.

You may obtain further information by examining the MCAI in the AD
docket.

Relevant Service Information

    Bombardier, Inc. has issued Service Bulletin 84-32-87, Revision B,
dated November 22, 2011; and Service Bulletin 84-32-88, dated February
16, 2011. Goodrich has issued Service Bulletin 08 60197 001-32-70 R2,
dated February 1, 2011. The actions described in this service
information are intended to correct the unsafe condition identified in
the MCAI.

FAA's Determination and Requirements of This Proposed AD

    This product has been approved by the aviation authority of another
country, and is approved for operation in the United States. Pursuant
to our bilateral agreement with the State of Design Authority, we have
been notified of the unsafe condition described in the MCAI and service
information referenced above. We are proposing this AD because we
evaluated all pertinent information and determined an unsafe condition
exists and is likely to exist or develop on other products of the same
type design.

Costs of Compliance

    Based on the service information, we estimate that this proposed AD
would affect about 83 products of U.S. registry. We also estimate that
it would take about 17 work-hour per product to comply with the basic
requirements of this proposed AD. The average labor rate is $85 per
work-hour. Required parts would cost about $5,205 per product. Where
the service information lists required parts costs that are covered
under warranty, we have assumed that there will be no charge for these
parts. As we do not control warranty coverage for affected parties,
some parties may incur costs higher than estimated here. Based on these
figures, we estimate the cost of the proposed AD on U.S. operators to
be $551,950, or $6,650 per product.
    In addition, we estimate that any necessary follow-on actions would
take about 3 work-hours and require parts costing $4,643, for a cost of
$4,898 per product. We have no way of determining the number of
products that may need these actions.

Authority for This Rulemaking

    Title 49 of the United States Code specifies the FAA's authority to
issue rules on aviation safety. Subtitle I, section 106, describes the
authority of the FAA Administrator. ``Subtitle VII: Aviation
Programs,'' describes in more detail the scope of the Agency's
authority.
    We are issuing this rulemaking under the authority described in
``Subtitle VII, Part A, Subpart III, Section 44701: General
requirements.'' Under that section, Congress charges the FAA with
promoting safe flight of civil aircraft in air commerce by prescribing
regulations for practices, methods, and procedures the Administrator
finds necessary for safety in air commerce. This regulation is within
the scope of that authority because it addresses an unsafe condition
that is likely to exist or develop on products identified in this
rulemaking action.

Regulatory Findings

    We determined that this proposed AD would not have federalism
implications under Executive Order 13132. This proposed AD would not
have a substantial direct effect on the States, on the relationship
between the national Government and the States, or on the distribution
of power and responsibilities among the various levels of government.
    For the reasons discussed above, I certify this proposed
regulation:
    1. Is not a ``significant regulatory action'' under Executive Order
12866;
    2. Is not a ``significant rule'' under the DOT Regulatory Policies
and Procedures (44 FR 11034, February 26, 1979);
    3. Will not affect intrastate aviation in Alaska; and
    4. Will not have a significant economic impact, positive or
negative, on a substantial number of small entities under the criteria
of the Regulatory Flexibility Act.
    We prepared a regulatory evaluation of the estimated costs to
comply with this proposed AD and placed it in the AD docket.

List of Subjects in 14 CFR Part 39

    Air transportation, Aircraft, Aviation safety, Incorporation by
reference, Safety.

The Proposed Amendment

    Accordingly, under the authority delegated to me by the
Administrator, the FAA proposes to amend 14 CFR part 39 as follows:

PART 39--AIRWORTHINESS DIRECTIVES

    1. The authority citation for part 39 continues to read as follows:

    Authority:  49 U.S.C. 106(g), 40113, 44701.

Sec.  39.13  [Amended]

    2. The FAA amends Sec.  39.13 by adding the following new AD:

Bombardier, Inc.: Docket No. FAA-2012-0726; Directorate Identifier
2012-NM-023-AD.

(a) Comments Due Date

    We must receive comments by September 17, 2012.

(b) Affected ADs

    None.

(c) Applicability

    This AD applies to Bombardier, Inc. Model DHC-8-400, -401, and -
402 airplanes, certificated in any category, serial numbers 4001
through 4346 inclusive.

(d) Subject

    Air Transport Association (ATA) of America Code 32: Landing
Gear.

(e) Reason

    This AD was prompted by cases of on-ground hydraulic
accumulator/screw cap/end cap failure, resulting in high-energy
impact damage to adjacent systems and structure. We are issuing this
AD to prevent failure of the screw caps and/or end caps of the
hydraulic and parking brake accumulators, which could result in
damage to the airplane's primary structures, with potential adverse
effect on the airplane's controllability.

(f) Compliance

    You are responsible for having the actions required by this AD
performed within the compliance times specified, unless the actions
have already been done.

(g) Inspect/Replace the Parking Brake Hydraulic Accumulator

    For airplanes having serial numbers 4001 through 4337 inclusive:
Within 1,200 flight hours or 6 months after the effective date of
this AD, whichever comes first, inspect the parking brake hydraulic
accumulator to determine the part number and serial number. Inspect
to determine the part number and serial number in accordance with
the Accomplishment Instructions of

Bombardier Service Bulletin 84-32-88, dated February 16, 2011.
    (1) If the part number of the parking brake hydraulic
accumulator can be determined by the inspection required by
paragraph (g) of this AD; and is not identified in paragraph 1.,
Effectivity, of Goodrich Service Bulletin 08 60197 001-32-70 R2,
dated February 1, 2011: No further action is required by this
paragraph.
    (2) If the part number and serial number of the parking brake
hydraulic accumulator cannot be determined by the inspection
required by paragraph (g) of this AD; or is identified in paragraph
1., Effectivity, of Goodrich Service Bulletin 08 60197 001-32-70 R2,
dated February 1, 2011: Before further flight, replace the parking
brake hydraulic accumulator, in accordance with the Accomplishment
Instructions of Bombardier Service Bulletin 84-32-88, dated February
16, 2011.

(h) Relocate the Parking Brake Hydraulic Accumulator

    (1) For airplanes having serial numbers 4001 through 4068
inclusive, 4070 through 4214 inclusive, 4214, 4216, 4219 through
4261 inclusive, and 4263 through 4346 inclusive: Within 6,000 flight
hours after the effective date of this AD, relocate the parking
brake hydraulic accumulator, in accordance with the Accomplishment
Instructions of Bombardier Service Bulletin 84-32-87, Revision B,
dated November 22, 2011.
    (2) Accomplishing the actions specified in paragraph (h)(1) of
this AD in accordance with previous revisions of Bombardier Service
Bulletin 84-32-87 does not meet the requirements of paragraph (h)(1)
of this AD.

(i) Other FAA AD Provisions

    The following provisions also apply to this AD:
    (1) Alternative Methods of Compliance (AMOCs): The Manager, New
York Aircraft Certification Office (ACO), FAA, has the authority to
approve AMOCs for this AD, if requested using the procedures found
in 14 CFR 39.19. In accordance with 14 CFR 39.19, send your request
to your principal inspector or local Flight Standards District
Office, as appropriate. If sending information directly to the ACO,
send it to ATTN: Program Manager, Continuing Operational Safety,
FAA, New York ACO, 1600 Stewart Avenue, Suite 410, Westbury, New
York 11590; telephone<PHONE_NUMBER>; fax<PHONE_NUMBER>. Before using
any approved AMOC, notify your appropriate principal inspector, or
lacking a principal inspector, the manager of the local flight
standards district office/certificate holding district office. The
AMOC approval letter must specifically reference this AD.
    (2) Airworthy Product: For any requirement in this AD to obtain
corrective actions from a manufacturer or other source, use these
actions if they are FAA-approved. Corrective actions are considered
FAA-approved if they are approved by the State of Design Authority
(or their delegated agent). You are required to assure the product
is airworthy before it is returned to service.

(j) Related Information

    Refer to MCAI Canadian Airworthiness Directive CF-2012-04, dated
January 13, 2012, and the service information identified in
paragraphs (j)(1) through (j)(3) of this AD, for related
information.
    (1) Bombardier Service Bulletin 84-32-87, Revision B, dated
November 22, 2011.
    (2) Bombardier Service Bulletin 84-32-88, dated February 16,
2011.
    (3) Goodrich Service Bulletin 08 60197 001-32-70 R2, dated
February 1, 2011.

    Issued in Renton, Washington, on July 20, 2012.
Kalene C. Yanamura,
Acting Manager, Transport Airplane Directorate, Aircraft Certification
Service.
[FR Doc. 2012-18588 Filed 8-1-12; 8:45 am]
BILLING CODE 4910-13-P


[Federal Register: May 29, 2007 (Volume 72, Number 102)]
[Notices]
[Page 29492]
[DOCID:fr29my07-34]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP07-452-000]

Eastern Shore Natural Gas Company; Notice of Interruptible
Revenue Sharing Report

May 21, 2007.
    Take notice that on May 16, 2007, Eastern Shore Natural Gas Company
(Eastern Shore) tendered for filing its Interruptible Revenue Sharing
Report pursuant to Section 37 of the General Terms and Conditions of
its FERC Tariff and Article V, Paragraph 6 of the Stipulation and
Agreement in Docket No. RP02-34-000.
    Eastern Shore states that it intends to credit a total of $144,925,
inclusive of $6,033 of interest, to its firm transportation customers
on or about July 1, 2007.
    Eastern states that the credit amount represents 90 percent of the
net revenues received by Eastern Shore under Rate Schedule IT in excess
of the cost of service allocated to such rate schedule for the period
April 2006 through March 2007.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the date as indicated
below. Anyone filing an intervention or protest must serve a copy of
that document on the Applicant. Anyone filing an intervention or
protest on or before the intervention or protest date need not serve
motions to intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time May 29, 2007.

Kimberly D. Bose,
Secretary.
[FR Doc. E7-10183 Filed 5-25-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 160 (Friday, August 17, 2018)]
[Proposed Rules]
[Page 41039]
[FR Doc No: 2018-17349]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 721

[EPA-HQ-OPPT-2017-0414; FRL-9981-82]
RIN 2070-AB27

Significant New Use Rules on Certain Chemical Substances

AGENCY: Environmental Protection Agency (EPA).

ACTION: Proposed rule.

-----------------------------------------------------------------------

SUMMARY: EPA is proposing significant new use rules (SNURs) under the
Toxic Substances Control Act (TSCA) for 27 chemical substances which
were the subject of premanufacture notices (PMNs). The chemical
substances are subject to Orders issued by EPA pursuant to section 5(e)
of TSCA. This action would require persons who intend to manufacture
(defined by statute to include import) or process any of these 27
chemical substances for an activity that is designated as a significant
new use by these rules to notify EPA at least 90 days before commencing
that activity. The required notification initiates EPA's evaluation of
the intended use within the applicable review period. Persons may not
commence manufacture or processing for the significant new use until
EPA has conducted a review of the notice, made an appropriate
determination on the notification, and has taken such actions as are
required with that determination. In addition to this notice of
proposed rulemaking, EPA is issuing the action as a direct final rule
elsewhere in this issue of the Federal Register.

DATES: Comments must be received on or before September 17, 2018.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2017-0414, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute.
     Mail: Document Control Office (7407M), Office of Pollution
Prevention and Toxics (OPPT), Environmental Protection Agency, 1200
Pennsylvania Ave. NW, Washington, DC 20460-0001.
     Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at http://www.epa.gov/dockets/contacts.html.
    Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT:
    For technical information contact: Kenneth Moss, Chemical Control
Division (7405M), Office of Pollution Prevention and Toxics,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number:<PHONE_NUMBER>; email address:
[email protected].
    For general information contact: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].

SUPPLEMENTARY INFORMATION: In addition to this Notice of Proposed
Rulemaking, EPA is issuing the action as a direct final rule elsewhere
in this issue of the Federal Register. For further information about
the proposed significant new use rules, please see the information
provided in the direct final action, with the same title, that is
located in the ``Rules and Regulations'' section of this issue of the
Federal Register.

List of Subjects in 40 CFR Part 721

    Environmental protection, Chemicals, Hazardous substances,
Reporting and recordkeeping requirements.

    Dated: August 3, 2018.
Mark A. Hartman,
Acting Director, Office of Pollution Prevention and Toxics.
[FR Doc. 2018-17349 Filed 8-16-18; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 76, Number 166 (Friday, August 26, 2011)]
[Notices]
[Page 53428]
[FR Doc No: 2011-21819]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 12924-002; Project No. 14077-000]

Free Flow Power Corporation; Northland Power Mississippi River
LLC; Notice of Competing Preliminary Permit Applications Accepted for
Filing and Soliciting Comments, Motions To Intervene, and Competing
Applications

    Free Flow Power Corporation (Free Flow) and Northland Power
Mississippi River LLC (Northland) filed preliminary permit
applications, pursuant to section 4(f) of the Federal Power Act,
proposing to study the feasibility of developing hydropower projects
hydropower on the Mississippi River, in Warren County, Mississippi, and
Tensas and Madison Parishes, Louisiana. Both applications were filed
electronically and given the filing date of February 1, 2011, at 8:30
a.m. The sole purpose of a preliminary permit, if issued, is to grant
the permit holder priority to file a license application during the
permit term. A preliminary permit does not authorize the permit holder
to perform any land-disturbing activities or otherwise enter upon lands
or waters owned by others without the owners' express permission.
    The proposed projects are described as follows:

    Free Flow's hydrokinetic Project, Project No. 12924-002 would
consist of: (1) Up to 2,250 SmartTurbine generating units installed
in arrays on the bottom of the river; (2) the total capacity of the
installation would be up to 90,000 kilowatts; (3) flexible cables
would convey each array's power to a metering station; and (4) a
transmission line would interconnect with the power grid. The
proposed project would have an average annual generation of
197,100,000 kilowatt-hours (kWh), which would be sold to a local
utility.
    Northland's hydrokinetic Project, Project No. 14077-000 would
consist of: (1) Up to 677 TREK generating units installed in a
matrix on the bottom of the river; (2) the total capacity of the
installation would be up to 169,000 kilowatts; (3) shielded
underwater cables would convey each matrix power to a substation;
and (4) a transmission line would interconnect with the power grid.
The proposed project would have an average annual generation of
1,482,000,000 kWh, which would be sold to a local utility.
    Applicants Contact: For Free Flow: Ramya Swaminathan, Free Flow
Power Corporation, 239 Causeway Street, Boston, MA 02114; phone
(978) 283-2822. For Northland: Tim Richardson, 30 St. Clair Avenue
West, 17th Floor, Toronto, Ontario, Canada; phone<PHONE_NUMBER>.
    FERC Contact: Michael Spencer,<PHONE_NUMBER>.

    Deadline for filing comments, motions to intervene, competing
applications (without notices of intent), or notices of intent to file
competing applications: 60 days from the issuance of this notice.
Competing applications and notices of intent must meet the requirements
of 18 CFR 4.36. Comments, motions to intervene, notices of intent, and
competing applications may be filed electronically via the Internet.
See 18 CFR 385.2001(a)(1)(iii) and the instructions on the Commission's
Web site (http://www.ferc.gov/docs-filing/ferconline.asp) under the
``eFiling'' link. For a simpler method of submitting text-only
comments, click on ``Quick Comment.'' For assistance, please contact
FERC Online Support at<EMAIL_ADDRESS>call toll-free at
(866) 208-3676; or, for TTY, contact<PHONE_NUMBER>. Although the
Commission strongly encourages electronic filing, documents may also be
paper-filed. To paper-file, mail an original and eight copies to:
Kimberly D. Bose, Secretary, Federal Energy Regulatory Commission, 888
First Street, NE., Washington, DC 20426.
    More information about this project, including a copy of the
application, can be viewed or printed on the ``eLibrary'' link of the
Commission's Web site at http://www.ferc.gov/docs-filing/elibrary.asp.
Enter the docket number (P-12924-002, or P-14077-000) in the docket
number field to access the document. For assistance, contact FERC
Online Support.

    Dated: August 19, 2011.
Kimberly D. Bose,
Secretary.
[FR Doc. 2011-21819 Filed 8-25-11; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 213 (Monday, November 4, 2019)]
[Notices]
[Pages 59375-59376]
[FR Doc No: 2019-24067]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OAR-2016-0027; FRL-10001-72-OAR]

Agency Information Collection Activities: Information Collection
Request (ICR) for On-Highway Motorcycle Certification and Compliance
Program; EPA ICR Number 2535.02, OMB Control Number 2060-0710

AGENCY: Environmental Protection Agency.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) is planning to
submit an Information Collection Request (ICR) for on-highway
motorcycle emissions certification and compliance'' to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act. Before submitting the ICR to OMB for
review and approval, EPA is soliciting comments on specific aspects of
the proposed information collection as described below. The current
ICR, under which on-highway motorcycles are included, is scheduled to
expire on March 31, 2020. An agency may not conduct or sponsor and a
person is not required to respond to a collection of information unless
it displays a currently valid OMB control number.

DATES: Comments must be submitted on or before January 3, 2020.

ADDRESSES: Submit your comments, referencing docket ID number EPA-HQ-
OAR-2016-0027, to EPA online using EDOCKET (our preferred method), by
email to<EMAIL_ADDRESS>or by mail to: EPA Docket
Center, Environmental Protection Agency, Air and Radiation Docket,
Environmental Protection Agency, Mailcode: 6102T, 1200 Pennsylvania
Ave. NW, Washington, DC 20460.

FOR FURTHER INFORMATION CONTACT: Julian Davis, Environmental Protection
Agency, 2000 Traverwood, Ann Arbor, MI 48105; telephone number: (734)
214-4029; fax number:<PHONE_NUMBER>; email address:
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: EPA has established a public docket for this
ICR under Docket ID number EPA-HQ-OAR-2016-0027, which is available for
public viewing at the Air and Radiation Docket in the EPA Docket Center
(EPA/DC), EPA West, Room B102, 1301 Constitution Ave. NW, Washington,
DC. The EPA Docket Center Public Reading Room is open from 8:30 a.m. to
4:30 p.m., Monday through Friday, excluding legal holidays. The
telephone number for the Reading Room is<PHONE_NUMBER>, and the
telephone number for the Air and Radiation Docket is<PHONE_NUMBER>. An
electronic version of the public docket is available through EPA
Dockets (EDOCKET) at http://www.epa.gov/edocket. Use EDOCKET to obtain
a copy of the draft collection of information, submit or view public
comments, access the index listing of the contents of the public
docket, and to access those documents in the public docket that are
available electronically. Once in the system, select ``search,'' then
key in the docket ID number identified above. Any comments related to
this ICR should be submitted to EPA within 60 days of this notice.
EPA's policy is that public comments, whether submitted electronically
or in paper, will be made available for public viewing in EDOCKET as
EPA receives them and without change, unless the comment contains
copyrighted material, CBI, or other information whose public disclosure
is restricted by statute. When EPA identifies a comment containing
copyrighted material, EPA will provide a reference to that material in
the version of the comment that is placed in EDOCKET. The entire
printed comment, including the copyrighted material, will be available
in the public docket. Although identified as an item in the official
docket, information claimed as CBI, or whose disclosure is otherwise
restricted by statute, is not included in the official public docket,
and will not be available for public viewing in EDOCKET. For further
information about the electronic docket, see EPA's Federal Register
notice describing the electronic docket at 67 FR 38102 (May 31, 2002),
or go to http://www.epa.gov./edocket.
    Affected entities: Entities potentially affected by this action are
on-highway motorcycle manufacturers and importers.
    Title: Information Collection Request (ICR) for On-Highway
Motorcycle Certification and Compliance Program.
    Abstract: Under the Clean Air Act (42 U.S.C. 7521 et seq.)
manufacturers and importers of on-highway motorcycles must have a
certificate of conformity issued by EPA covering any vehicle they
intend to offer for sale in the United States. A certificate of
conformity represents that the respective vehicle conforms to all
applicable emissions requirements. In issuing a certificate of
conformity, EPA reviews vehicle information and emissions test data to
determine if the required testing has been performed and the required
emissions levels have been demonstrated. After a certificate of
conformity has been issued, the Agency may request additional
information to verify that the product continues to meet its certified
emissions standards throughout its useful life. An agency may not
conduct or sponsor, and a person is not required to respond to, a
collection of information unless it displays a currently valid OMB
control number. The OMB control numbers for EPA's regulations in 40 CFR
are listed in 40 CFR part 9. The EPA would like to solicit comments to:
    (i) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the Agency,
including whether the information will have practical utility;
    (ii) Evaluate the accuracy of the Agency's estimate of the burden
of the proposed collection of information, including the validity of
the methodology and assumptions used;
    (iii) Enhance the quality, utility, and clarity of the information
to be collected; and
    (iv) Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
    EPA will consider the comments received and amend for the ICR as
appropriate. The final ICR package will then be submitted to OMB for
review and approval. At that time, EPA will issue another Federal
Register notice to announce the submission of the ICR to OMB and the
opportunity to submit additional comments to OMB.
    The current ICR for on-highway motorcycle emissions certification
and compliance information is set to expire on March 31, 2019. This
program was previously approved under the current ICR for highway
motorcycle certification and compliance [EPA ICR No. 2535.01, OMB
Control Number 2060-NEW].
    Burden statement: EPA estimates that 70 respondents will submit
information each year spending a total of 1,668,593 hours and incurring
an annualized cost of 1.188 million dollars. The average burden per
respondent varies greatly; it is a function of the diversity of the
products produced or imported. (A large, diversified motor vehicle
manufacturer will have a much greater burden than a small importer of a
few identical vehicles.) Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
or disclose or provide information to or for a Federal agency.

This includes the time needed to review instructions; develop, acquire,
install, and utilize technology and systems for the purposes of
collecting, validating, and verifying information, processing and
maintaining information, and disclosing and providing information;
adjust the existing ways to comply with any previously applicable
instructions and requirements; train personnel to be able to respond to
a collection of information; search data sources; complete and review
the collection of information; and transmit or otherwise disclose the
information.
    Form numbers: The EPA has developed forms, some of which are Excel-
based, for the compliance programs in this ICR. Manufacturers may
download these forms from EPA's website at https://www.epa.gov/ve-certification/certification-non-electric-motorcycles and submit these
forms through the EPA's engine and vehicle compliance information
system's (EV-CIS) document module. All of these forms are available for
review in the Docket EPA-HQ-OAR-2016-0027.

------------------------------------------------------------------------
                                                           Current form
          Form title                 New or previous            No.
------------------------------------------------------------------------
Highway Motorcycle HC+NOX       Previous................        5900-339
 Average Exhaust Emissions
 Model Year Report.
Manufacturer Production Report  Previous................         5900-90
 for Engine/Equipment
 Manufacturers--Heavy-Duty,
 Nonroad, and Highway
 Motorcycles.
List of Emissions Related       New
 Components.
Catalyst Information..........  Previous................        5900-464
------------------------------------------------------------------------

    Respondents/affected entities: Entities potentially affected by
this action are on-highway motorcycle manufacturers and importers.
    Estimated number of respondents: 70.
    Frequency of response: Quarterly and annually.
    Estimated total annual hour burden: 5,453.
    Estimated total annual cost: $1,188,628.31, which includes
$18,680.00 annualized operation and maintenance costs, $42,664.00
annualized capital/startup costs, and $988,626.31 annual labor costs.
    These estimates reflect an update to the previous cost estimates
for on-highway motorcycles previously culled and compiled for the
current ICR for highway motorcycle certification and compliance.
Previously, we estimated more manufacturers that would maintain their
own testing and certification facility. Currently, a larger percentage
of manufacturers use contract test facilities and utilize carry over
data for certification and compliance requirements.

    Dated: October 24, 2019.
Byron J. Bunker,
Director, Compliance Division, Office of Transportation and Air
Quality, Office of Air and Radiation.
[FR Doc. 2019-24067 Filed 11-1-19; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 86, Number 123 (Wednesday, June 30, 2021)]
[Notices]
[Pages 34754-34757]
[FR Doc No: 2021-13943]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-N-1960]

Agency Information Collection Activities; Proposed Collection;
Comment Request; MedWatch: The Food and Drug Administration Medical
Products Reporting Program

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, Agency, or we) is
announcing an opportunity for public comment on the proposed collection
of certain information by the Agency. Under the Paperwork Reduction Act
of 1995 (PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on information collection
associated with FDA's MedWatch adverse experience reporting (AER)
program.

DATES: Submit either electronic or written comments on the collection
of information by August 30, 2021.

ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. Electronic comments
must be submitted on or before August 30, 2021. The https://www.regulations.gov electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of August 30, 2021. Comments
received by mail/hand delivery/courier (for written/paper submissions)
will be considered timely if they are postmarked or the delivery
service acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked, and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2014-N-1960 for ``MedWatch: The FDA Medical Products Reporting
Program.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential

Submissions,'' publicly viewable at https://www.regulations.gov or at
the Dockets Management Staff between 9 a.m. and 4 p.m., Monday through
Friday,<PHONE_NUMBER>.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on https://www.regulations.gov.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly available, you
can provide this information on the cover sheet and not in the body of
your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852,<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Domini Bean, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3521), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

MedWatch: The FDA Medical Products Reporting Program

OMB Control Number 0910-0291--Extension

    This information collection supports FDA laws and regulations
governing adverse event reports and product experience reports for FDA-
regulated products. The Federal Food, Drug, and Cosmetic Act (FD&C Act)
(21 U.S.C. 353b, 355, 360i, 360l, 379aa, and 393) and the Public Health
Service Act (42 U.S.C. 262) authorize FDA to collect adverse event
reports and product experience reports from regulated industry and to
monitor the safety of drugs, biologics, medical devices, and dietary
supplements. These reporting and recordkeeping requirements are found
in FDA regulations, discussed in Agency guidance, and included in
Agency forms. Although there are no laws or regulations mandating
postmarket reporting for medical foods, infant formula, cosmetics, or
tobacco products, we encourage voluntary reporting of adverse
experiences associated with these products.
    To facilitate both consumer and industry reporting of adverse
events and experiences with FDA-regulated products, we developed the
MedWatch program. The MedWatch program allows anyone to submit reports
to FDA on adverse events, including injuries and/or deaths, as well as
other product experiences associated with the products we regulate.
While the MedWatch program provides for both paper-based and electronic
reporting, this information collection covers paper-based reporting.
Requirements regarding mandatory reporting of adverse events or product
problems have been codified in parts 310, 314, 329, 600, and 803 (21
CFR 310, 314, 600, and 803), and specified in sections 503B, 760, and
761 of the FD&C Act (21 U.S.C. 353b, 379aa, and 379aa-1). Mandatory
reporting of adverse events for human cells, tissues, and cellular- and
tissue-based products (HCT/Ps) have been codified in Sec.  1271.350 (21
CFR 1271.350). Other postmarketing reporting associated with
requirements found in sections 201, 502, 505, and 701 (21 U.S.C. 321,
352, 355, and 371) of the FD&C Act and applicable to certain drug
products with and without approved applications are approved under OMB
control number 0910-0230.
    Since 1993, mandatory adverse event reporting has been supplemented
by voluntary reporting by healthcare professionals, patients, and
consumers via the MedWatch reporting process. To carry out its
responsibilities, the Agency needs to be informed when an adverse
event, product problem, error with use of a human medical product, or
evidence of therapeutic failure is suspected or identified in clinical
use. When FDA receives this information from healthcare professionals,
patients, or consumers, the report becomes data that will be used to
assess and evaluate the risk associated with the product. FDA will take
any necessary action to reduce, mitigate, or eliminate the public's
exposure to the risk through regulatory and public health
interventions.
    To implement these reporting provisions for FDA-regulated products
(except vaccines) during their post-approval and marketed lifetimes, we
developed the following three forms, available for download from our
website or upon request to the Agency: (1) Form FDA 3500 may be used
for voluntary (i.e., not mandated by law or regulation) reporting by
healthcare professionals; (2) Form FDA 3500A is used for mandatory
reporting (i.e., required by law or regulation); and (3) Form FDA
3500B, available in English and Spanish, is written in plain language
and may be used for voluntary reporting (i.e., not mandated by law or
regulation) by consumers (i.e., patients and their caregivers).
Respondents to the

information collection are healthcare professionals, medical care
organizations and other user facilities (e.g., extended care
facilities, ambulatory surgical centers), consumers, manufacturers of
biological, food products including dietary supplements and special
nutritional products (e.g., infant formula and medical foods),
cosmetics, drug products or medical devices, and importers.

Use of Form FDA 3500 (Voluntary Reporting)

    This voluntary version of the form may be used by healthcare
professionals to submit all reports not mandated by Federal law or
regulation. Individual healthcare professionals are not required by law
or regulation to submit reports to the Agency or the manufacturer, with
the exception of certain adverse events following immunization with
vaccines as mandated by the National Childhood Vaccine Injury Act of
1986. Reports for vaccines are not submitted via MedWatch or MedWatch
forms, but are submitted to the Vaccines Adverse Event Reporting System
(VAERS; see http://vaers.hhs.gov), which is jointly administered by FDA
and the Centers for Disease Control and Prevention.
    Hospitals are not required by Federal law or regulation to submit
reports associated with drug products, biological products, or special
nutritional products. However, hospitals and other user facilities are
required by Federal law to report medical device-related deaths and
serious injuries.
    Under Federal law and regulation (section 761(b)(1) of the FD&C
Act), a dietary supplement manufacturer, packer, or distributor whose
name appears on the label of a dietary supplement marketed in the
United States is required to submit to FDA any serious adverse event
report it receives regarding use of the dietary supplement in the
United States. However, FDA bears the burden to gather and review
evidence that a dietary supplement may be adulterated under section 402
of the FD&C Act after that product is marketed. Therefore, the Agency
depends on the voluntary reporting by healthcare professionals and
especially by consumers of suspected serious adverse events and product
quality problems associated with the use of dietary supplements. All
dietary supplement reports were originally received by the Agency on
paper versions of Form FDA 3500 (by mail or fax). Today, electronic
reports may be sent to the Agency via an online submission route called
the Safety Reporting Portal at http://www.safetyreporting.hhs.gov/. In
that case, the Form FDA 3500 is not used.
    Form FDA 3500 may be used to report to the Agency adverse events,
product problems, product use errors, and therapeutic failures. The
form is provided in both paper and electronic formats. Reporters may
mail or fax paper forms to the Agency. A fillable .pdf version of the
form is available at https://www.accessdata.fda.gov/scripts/medwatch/
or electronically submit a report via the MedWatch Online Voluntary
Reporting Form at https://www.accessdata.fda.gov/scripts/medwatch/.
Reporting is supported for drugs, non-vaccine biologicals, medical
devices, food products, special nutritional products, cosmetics, and
non-prescription human drug products marketed without an approved
application. The paper form may also be used to submit reports about
dietary supplements. Electronic reports for dietary supplements may be
submitted to the Agency via an online submission route called the
Safety Reporting Portal at http://www.safetyreporting.hhs.gov/.
Electronic reports for tobacco products may be submitted to the Agency
via the tobacco questionnaire within the online Safety Reporting Portal
at http://www.safetyreporting.hhs.gov/.

Use of Form FDA 3500A--Mandatory Reporting

Drug and Biological Products

    Sections 503B, 505(j), and 704 of the FD&C Act (21 U.S.C. 374)
require that important safety information relating to all human
prescription drug products be made available to FDA in the event it
becomes necessary to take appropriate action to ensure protection of
the public health. Mandatory reporting of adverse events for HCT/Ps is
codified in Sec.  1271.350. Consistent with statutory requirements,
information is required to be submitted electronically and therefore we
account for most all reports under OMB control number 0910-0645,
established to support electronic reporting to our MedWatch program. At
the same time, regulations provided for waivers from the electronic
submission requirements and we therefore account for paper-based
reporting in this information collection.

Medical Device Products

    Section 519 of the FD&C Act (21 U.S.C. 360i) requires manufacturers
and importers, of devices intended for human use to establish and
maintain records, make reports, and provide information as the
Secretary of Health and Human Services may by regulation reasonably
require to assure that such devices are not adulterated or misbranded
and to otherwise assure its safety and effectiveness. The Safe Medical
Device Act of 1990, signed into law on November 28, 1990, amends
section 519 of the FD&C Act. The amendment requires that user
facilities such as hospitals, nursing homes, ambulatory surgical
facilities, and outpatient treatment facilities report deaths related
to medical devices to FDA and to the manufacturer, if known. Serious
illnesses and injuries are to be reported to the manufacturer or to FDA
if the manufacturer is not known. These statutory requirements
regarding mandatory reporting have been codified by FDA under 21 CFR
part 803 (part 803). Part 803 mandates the use of the Form FDA 3500A
for reporting to FDA on medical devices. While most reporting
associated with medical device products is covered under OMB control
number 0910-0437, we retain coverage for paper-based adverse experience
report submissions in this collection.

Dietary Supplements

    Section 502(x) in the FD&C Act implements the requirements of The
Dietary Supplement and Nonprescription Drug Consumer Protection Act,
which became law (Pub. L. 109-462) on December 22, 2006. These
requirements apply to manufacturers, packers, and distributors of
nonprescription human drug products marketed without an approved
application. The law requires reports of serious adverse events to be
submitted to the Agency by manufacturers of dietary supplements.
Electronic reports for dietary supplements may be submitted using the
Safety Reporting Portal at http://www.safetyreporting.hhs.gov/. Paper-
based dietary supplement reports may be submitted using the MedWatch
Form FDA 3500A.

Use of Form FDA 3500B--Consumer Voluntary Reporting

    This voluntary version of the form may be used by consumers,
patients, or caregivers to submit reports not mandated by Federal law
or regulation. Individual consumers, patients, or caregivers are not
required by law or regulation to submit reports to the Agency or the
manufacturer. FDA supports and encourages direct reporting to the
Agency by consumers of suspected adverse events and other product
problems associated with human medical products, food, dietary
supplements, and cosmetic products and invite these respondents to
visit our

website at https://www.fda.gov/safety/report-problem-fda for more
information. Since the inception of the MedWatch program in July 1993,
the program has been promoting and facilitating voluntary reporting by
both the public and healthcare professionals. FDA has further
encouraged voluntary reporting by requiring inclusion of the MedWatch
toll-free phone number or the MedWatch internet address on all
outpatient drug prescriptions dispensed, as mandated by section 17 of
the Best Pharmaceuticals for Children Act (Pub. L. 107-109).
    Section 906 of the FDA Amendments Act amended section 502(n) of the
FD&C Act, mandating that published direct-to-consumer advertisements
for prescription drugs include the following statement printed in
conspicuous text (this includes vaccine products): ``You are encouraged
to report negative side effects of prescription drugs to the FDA. Visit
https://www.fda.gov/medwatch, or call 1-800-FDA-1088.'' Most private
vendors of consumer medication information, the drug product-specific
instructions dispensed to consumers at outpatient pharmacies, remind
patients to report ``side effects'' to FDA and provide contact
information to permit MedWatch reporting.
    Since 2013, FDA has made available the 3500B form. Proposed during
the previous authorization in 2012, the 3500B form is a version of the
3500 form that is tailored for consumers and written in plain language
in conformance with the Plain Writing Act of 2010 (https://www.govinfo.gov/content/pkg/PLAW-111publ274/pdf/PLAW-111publ274.pdf).
The 3500B form evolved from several iterations of draft versions, with
input from human factors experts, from other regulatory agencies and
with extensive input from consumer advocacy groups and the public.
Since 2019, the 3500B form has been available in Spanish at https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/reporting-serious-problems-fda and available to
upload electronically since 2021 at https://www.accessdata.fda.gov/scripts/medwatch/index.cfm?action=reporting.spanish.
    Form FDA 3500B, may be used to report adverse events, product
problems, product use errors and problems after switching from one
product maker to another maker to the Agency. The form is provided in
both paper and electronic formats. Respondents may submit reports by
mail or fax paper forms to the Agency or electronically submit a report
via the MedWatch Online Voluntary Reporting Form at https://www.accessdata.fda.gov/scripts/medwatch/. A fillable .pdf version of
the form, available at http://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM349464.pdf may be downloaded, completed,
and mailed or faxed to the Agency. Reporting is supported for drugs,
non-vaccine biologicals, medical devices, food products, special
nutritional products, cosmetics, and non-prescription human drug
products marketed without an approved application. The paper form may
also be used to submit reports about dietary supplements. Electronic
reports for dietary supplements may be submitted to the Agency via an
online submission route called the Safety Reporting Portal at http://www.safetyreporting.hhs.gov/. Electronic reports for tobacco products
may be submitted to the Agency via the tobacco questionnaire within the
online Safety Reporting Portal at http://www.safetyreporting.hhs.gov/.
    We estimate the burden of this collection of information as
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of
FDA center or 21 CFR section and/    Number of     responses per   Total annual   Average burden    Total hours
           or FDA form              respondents     respondent       responses     per response
----------------------------------------------------------------------------------------------------------------
Center for Biologics Evaluation           14,727               1          14,727        0.66 (40           9,720
 and Research/Center for Drug                                                           minutes)
 Evaluation and Research: Form
 3500...........................
Form 3500A(Sec.  Sec.   310.305,             599              98          58,702            1.21          71,029
 314.80, 314.98, 600.80, and
 1271.350)......................
Form 3500A (Sec.   310.305                    50               2             100            1.21             121
 outsourcing facilities)........
Center for Devices and                     5,233               1           5,233        0.66 (40           3,454
 Radiological Health: Form 3500.                                                        minutes)
Form 3500A (part 803)...........           2,277             296         673,992            1.21         815,530
Center for Food Safety and                 1,793               1           1,793        0.66 (40           1,183
 Applied Nutrition: Form 3500...                                                        minutes)
Form 3500A......................           1,659               1           1,659            1.21           2,007
Center for Tobacco Products:                  39               1              39        0.66 (40              26
 Form 3500......................                                                        minutes)
All Centers: Form 3500B.........          13,750               1         13, 750        0.46 (28           6,325
                                                                                minutes)
Written requests for temporary                 1               1               1               1               1
 waiver under Sec.
 329.100(c)(2)..................
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............         909,396
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    We are retaining the currently approved burden estimates for the
information collection.

    Dated: June 24, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for Policy.
[FR Doc. 2021-13943 Filed 6-29-21; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register Volume 88, Number 112 (Monday, June 12, 2023)]
[Notices]
[Page 38122]
[FR Doc No: 2023-12470]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2022-0209]

Women of Trucking Advisory Board (WOTAB); Notice of Public
Meeting

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the WOTAB.

DATES: The meeting will be held on Thursday, June 29, 2023, from 10
a.m. to 4:30 p.m. ET. Requests for accommodations for a disability must
be received by Friday, June 23. Requests to submit written materials
for consideration during the meeting must be received no later than
Friday, June 23.

ADDRESSES: The meeting will be held virtually for its entirety. Please
register in advance of the meeting at www.fmcsa.dot.gov/wotab. Copies
of WOTAB task statements and an agenda for the entire meeting will be
made available at www.fmcsa.dot.gov/wotab at least 1 week in advance of
the meeting. Once approved, copies of the meeting minutes will be
available at the website following the meeting. You may visit the WOTAB
website at www.fmcsa.dot.gov/wotab for further information on the
committee and its activities.

FOR FURTHER INFORMATION CONTACT: Ms. Shannon L. Watson, Designated
Federal Officer, WOTAB, FMCSA, 1200 New Jersey Avenue SE, Washington,
DC 20590,<PHONE_NUMBER>, [email protected]. Any committee-related request
should be sent to the person listed in this section.

SUPPLEMENTARY INFORMATION:

I. Background

    WOTAB was created under the Federal Advisory Committee Act (FACA)
in accordance with section 23007(d)(1) of the Bipartisan Infrastructure
Law (BIL) (Pub. L. 117-58), which requires the Federal Motor Carrier
Safety Administration (FMCSA) to establish WOTAB. WOTAB will review and
report on policies that provide education, training, mentorship, and
outreach to women in the trucking industry and identify barriers and
industry trends that directly or indirectly discourage women from
pursuing and retaining careers in trucking.
    WOTAB operates in accordance with FACA under the terms of the WOTAB
charter, filed February 11, 2022.

II. Agenda

    WOTAB will begin consideration of Task 23-2, Ways to Expand
Existing Opportunities for Women in the Trucking Industry. For this and
all topics considered by the committee, FMCSA will include
presentations by Agency experts and those in the field under
discussion.

III. Public Participation

    The meeting will be open to the public via virtual platform.
Advance registration via the website is required.
    DOT is committed to providing equal access to this meeting for all
participants. If you need alternative formats or services due to a
disability, such as sign language interpretation or other ancillary
aids, please contact the person listed in the FOR FURTHER INFORMATION
CONTACT section by Friday, June 23.
    Oral comments from the public will be heard during designated
comment periods at the discretion of the WOTAB chair and Designated
Federal Officer. To accommodate as many speakers as possible, the time
for each commenter may be limited. Speakers are requested to submit a
written copy of their remarks for inclusion in the meeting records and
for circulation to WOTAB members. All prepared remarks submitted on
time will be accepted and considered as part of the record. Any member
of the public may present a written statement to the committee at any
time.

Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2023-12470 Filed 6-9-23; 8:45 am]
BILLING CODE 4910-EX-P